Skip to main content
Clinical Trials/IRCT20200827048547N1
IRCT20200827048547N1
Completed
Phase 3

Comparing the efficacy of Duloxetine with High tone diabetic peripheral neuropathic pain

Ahvaz University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Diabetic neuropathy.
Sponsor
Ahvaz University of Medical Sciences
Enrollment
30
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age over 18 years
  • Type 1 and 2 diabetes
  • 24\-hour mean pain score based on VAS pain visual scale\> 4mm

Exclusion Criteria

  • Mood Disorder
  • Disseminated anxiety disorder
  • Avoid substance use
  • A history of less than a year or more than 15 years of diabetes
  • Receive medication to control diabetic polyneuropathy within 2 weeks before starting the study
  • Existence of neuropathy due to another
  • Peripheral vascular disease
  • Pregnant or lactating women
  • History of epilepsy
  • Uncontrolled acute angle\-closure glaucoma

Outcomes

Primary Outcomes

Not specified

Similar Trials